Negative regulation of lamellipodium organization

pathway activity — cross-omics
GO:1902744Cross-omicsPROTEIN-MS → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Negative regulation of lamellipodium organization pathway is significantly associated with the RNA expression of multiple genes, with the LSCC cohort showing a particularly strong set of associations.

The most reproducible pathway-associated genes across cancer lineages are KANK1, PDSS1P1, and RNU7-119P, each associated with the pathway in up to 7 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Negative regulation of lamellipodium organization activity versus KANK1 in LSCC (Pearson r = 0.28).

Pathway-associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
LSCCKANK1 →+0.934+0.652<.001<.00137
UCECPDSS1P1 →+0.721+0.693.003.00134
UCECRNU7-119P →+1.794+0.819<.001<.00133
LSCCRNU6-1327P →+1.137+0.542.003.00233
GBMEIF1P1 →+0.657+0.416.001<.00133
GBMTCF3P1 →+0.278+0.382.006.00233
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:1902744 vs KANK1 — LSCC

Per-sample scatter of Negative regulation of lamellipodium organization activity vs KANK1 in LSCC.

Explore this scatter interactively →

Exploration